Ondansetron vs Tofacitinib
Ondansetron vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Ondansetron and Tofacitinib.
Mechanism of Action
Ondansetron: Selective 5-HT3 receptor antagonist.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Ondansetron — 3-5 hours; Tofacitinib — 3.2 hours.
Chemical Properties
Molecular Formula: Ondansetron — C18H19N3O; Tofacitinib — C16H20N6O.
Molecular Weight: Ondansetron — 293.3660 g/mol; Tofacitinib — 312.3700 g/mol.
Type: Ondansetron — Small molecule; Tofacitinib — Small molecule.